Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2026 ,inter alia, to consider and approve The standalone and consolidated ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Bharat Parenterals Ltd has informed BSE that its Board of Directors meeting is scheduled for May 18, 2026. The meeting will consider and approve the audited standalone and consolidated financial results for Q4 and the financial year ended March 31, 2026. The board will also review the audited annual financial statements and consider recommending a final dividend for FY 2025-26. Additionally, the trading window for designated persons has been closed since April 1, 2026, and will remain closed until 48 hours after the financial results are declared. This is a standard regulatory intimation under SEBI listing regulations.
This is a routine board meeting notice for annual results announcement. No specific financial details or warnings are provided in this filing. Shareholders should expect Q4 and full-year results to be announced after May 18, 2026.